Publication | Open Access
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough
38
Citations
20
References
2022
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1